BR9605886A - Processo para produção de composições de substância ativa na forma de uma solução sólida da substância atina em uma matriz de polímero e composição de substância ativa - Google Patents
Processo para produção de composições de substância ativa na forma de uma solução sólida da substância atina em uma matriz de polímero e composição de substância ativaInfo
- Publication number
- BR9605886A BR9605886A BR9605886A BR9605886A BR9605886A BR 9605886 A BR9605886 A BR 9605886A BR 9605886 A BR9605886 A BR 9605886A BR 9605886 A BR9605886 A BR 9605886A BR 9605886 A BR9605886 A BR 9605886A
- Authority
- BR
- Brazil
- Prior art keywords
- active substance
- substance
- solid solution
- polymer matrix
- atine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
- B01J2/20—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by expressing the material, e.g. through sieves and fragmenting the extruded length
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19509807A DE19509807A1 (de) | 1995-03-21 | 1995-03-21 | Verfahren zur Herstellung von Wirkstoffzubereitungen in Form einer festen Lösung des Wirkstoffs in einer Polymermatrix sowie mit diesem Verfahren hergestellte Wirkstoffzubereitungen |
| PCT/EP1996/001047 WO1996029061A1 (de) | 1995-03-21 | 1996-03-12 | Verfahren zur herstellung von wirkstoffzubereitungen in form einer festen lösung des wirkstoffs in einer polymermatrix sowie mit diesem verfahren hergestellte wirkstoffzubereitungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9605886A true BR9605886A (pt) | 1997-09-16 |
Family
ID=7757018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9605886A BR9605886A (pt) | 1995-03-21 | 1996-03-12 | Processo para produção de composições de substância ativa na forma de uma solução sólida da substância atina em uma matriz de polímero e composição de substância ativa |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5741519A (pt) |
| EP (1) | EP0760654B1 (pt) |
| JP (1) | JP4017661B2 (pt) |
| KR (1) | KR970703133A (pt) |
| CN (1) | CN1081458C (pt) |
| AT (1) | ATE204162T1 (pt) |
| AU (1) | AU5106996A (pt) |
| BR (1) | BR9605886A (pt) |
| CA (1) | CA2190882C (pt) |
| CZ (1) | CZ340596A3 (pt) |
| DE (2) | DE19509807A1 (pt) |
| ES (1) | ES2163008T3 (pt) |
| HU (1) | HUP9603530A3 (pt) |
| IL (1) | IL117532A0 (pt) |
| MX (1) | MX9605678A (pt) |
| NO (1) | NO313485B1 (pt) |
| WO (1) | WO1996029061A1 (pt) |
| ZA (1) | ZA962243B (pt) |
Families Citing this family (92)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE159426T1 (de) * | 1991-04-16 | 1997-11-15 | Nippon Shinyaku Co Ltd | Verfahren zur herstellung einer festen dispersion |
| US5567439A (en) * | 1994-06-14 | 1996-10-22 | Fuisz Technologies Ltd. | Delivery of controlled-release systems(s) |
| DE19509805A1 (de) * | 1995-03-21 | 1996-09-26 | Basf Ag | Transparente, schnell freisetzende Zubereitungen von nichtsteroidalen Analgetica |
| DE19602206A1 (de) * | 1996-01-23 | 1997-07-24 | Basf Ag | Zubereitungen nichtsteroidaler Analgetika |
| US6139872A (en) * | 1996-08-14 | 2000-10-31 | Henkel Corporation | Method of producing a vitamin product |
| DE19733505A1 (de) | 1997-08-01 | 1999-02-04 | Knoll Ag | Schnell wirksames Analgeticum |
| US6416786B1 (en) | 1998-12-11 | 2002-07-09 | Nostrum Pharmaceuticals, Inc. | Sustained release tablet containing hydrocolloid and cellulose ether |
| DE19901040A1 (de) * | 1999-01-14 | 2000-07-20 | Knoll Ag | Arzneiformen mit gesteuerter Freisetzung, enthaltend gut wasserlösliche Wirkstoffe |
| DE19933289A1 (de) * | 1999-07-15 | 2001-01-18 | Basf Ag | Verfahren zur Herstellung eines Granulats aus einer Schmelze |
| US6327354B1 (en) * | 1999-08-17 | 2001-12-04 | Ameritech Corporation | Methods, systems, and articles for providing a family telecommunication service |
| DE19945982A1 (de) * | 1999-09-24 | 2001-03-29 | Knoll Ag | Geschwindigkeitsbestimmte Partikel |
| PL207590B1 (pl) * | 1999-09-24 | 2011-01-31 | Janssen Pharmaceutica Nv | Cząstka stanowiąca dyspersję stałą oraz postać dawkowania, sposób ich otrzymywania i zastosowanie |
| US6264981B1 (en) † | 1999-10-27 | 2001-07-24 | Anesta Corporation | Oral transmucosal drug dosage using solid solution |
| US7364752B1 (en) | 1999-11-12 | 2008-04-29 | Abbott Laboratories | Solid dispersion pharamaceutical formulations |
| DE60028754T2 (de) * | 1999-11-12 | 2007-05-31 | Abbott Laboratories, Abbott Park | Feste dispersion mit ritonavir, fenofibrat oder griseofulvin |
| DE10026698A1 (de) * | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
| US7842308B2 (en) | 2001-01-30 | 2010-11-30 | Smithkline Beecham Limited | Pharmaceutical formulation |
| US7883721B2 (en) | 2001-01-30 | 2011-02-08 | Smithkline Beecham Limited | Pharmaceutical formulation |
| GB0102342D0 (en) | 2001-01-30 | 2001-03-14 | Smithkline Beecham Plc | Pharmaceutical formulation |
| US20050175687A1 (en) * | 2001-01-30 | 2005-08-11 | Mcallister Stephen M. | Pharmaceutical formulations |
| JPWO2003034302A1 (ja) * | 2001-10-15 | 2005-02-03 | 株式会社シュタルク | コンテンツ配信用サーバ及びこれを備えたコンテンツ配信システム |
| US7050559B2 (en) * | 2001-12-21 | 2006-05-23 | Bellsouth Intellectual Property Corporation | Monitoring a call forwarded to a network-based voice mail system |
| US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
| MXPA05000977A (es) * | 2002-08-12 | 2005-05-16 | Pfizer Prod Inc | Composiciones farmaceuticas de farmacos semiordenados y polimeros. |
| WO2004069138A2 (en) * | 2003-02-03 | 2004-08-19 | Novartis Ag | Pharmaceutical formulation |
| EP1638527B1 (en) * | 2003-06-27 | 2006-10-25 | BIOPROGRESS S.p.A. | Composite product obtainable by cogrinding of an active principle with a copolymer n-vinyl-2-pyrrolidone/vinyl-acetate |
| TW200526274A (en) | 2003-07-21 | 2005-08-16 | Smithkline Beecham Plc | Pharmaceutical formulations |
| DE10361596A1 (de) * | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| ES2289542T3 (es) * | 2003-08-06 | 2008-02-01 | Grunenthal Gmbh | Forma farmaceutica protegida contra un posible abuso. |
| DE102005005446A1 (de) * | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
| US8075872B2 (en) | 2003-08-06 | 2011-12-13 | Gruenenthal Gmbh | Abuse-proofed dosage form |
| DE102004020220A1 (de) * | 2004-04-22 | 2005-11-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform |
| DE10336400A1 (de) * | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
| US20070048228A1 (en) * | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
| DE102004032051A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform |
| US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
| US8377952B2 (en) * | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
| JP2007513147A (ja) * | 2003-12-04 | 2007-05-24 | ファイザー・プロダクツ・インク | 押し出し機を使用して、好ましくはポロキサマーとグリセリドを含有する多粒子結晶性医薬組成物を製造するための噴霧凝結方法 |
| SI1691787T1 (sl) * | 2003-12-04 | 2008-10-31 | Pfizer Prod Inc | Postopek za pripravo farmacevtskih produktov iz več delcev |
| BRPI0417338A (pt) * | 2003-12-04 | 2007-04-17 | Pfizer Prod Inc | formas de dosagem de azitromicina multiparticulada por processos a base de lìquido |
| CA2547597A1 (en) * | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Multiparticulate compositions with improved stability |
| US6984403B2 (en) * | 2003-12-04 | 2006-01-10 | Pfizer Inc. | Azithromycin dosage forms with reduced side effects |
| BRPI0416535A (pt) * | 2003-12-04 | 2007-01-09 | Pfizer Prod Inc | processo de congelamento por vaporização empregando um extrusor para preparar composições de azitromicina de multiparticulado contendo preferivelmente um poloxámero e um glicerìdeo |
| WO2005053652A1 (en) | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride |
| WO2005053639A2 (en) * | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Controlled release multiparticulates formed with dissolution enhancers |
| TW201240679A (en) * | 2004-03-12 | 2012-10-16 | Capsugel Belgium Nv | Pharmaceutical formulations |
| WO2005123052A1 (fr) * | 2004-06-18 | 2005-12-29 | Jiangsu Hengrui Medicine Co., Ltd. | Composition medicamenteuse contenant de l'ambroxol et de l'erdosteine ou de l'acetylcysteine |
| DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
| DE102004032103A1 (de) * | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
| KR101086254B1 (ko) * | 2004-11-04 | 2011-11-24 | 에스케이케미칼주식회사 | 생체이용률이 개선된 프란루카스트 고체분산체 조성물 및그 고체분산체의 제조방법 |
| DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| WO2006100281A2 (en) | 2005-03-22 | 2006-09-28 | Losan Pharma Gmbh | Solubilized ibuprofen |
| EP1800667A1 (en) | 2005-12-23 | 2007-06-27 | Losan Pharma GmbH | Rapidly solubilizing ibuprofen granulate |
| EP1968553A2 (en) * | 2005-11-09 | 2008-09-17 | Novartis AG | Process for making pharmaceutical compositions with a transient plasticizer |
| RU2403013C2 (ru) * | 2005-12-16 | 2010-11-10 | Ханми Фарм. Ко., Лтд. | Твердая дисперсия, содержащая активный ингредиент с низкой температурой плавления, и содержащая ее таблетка для перорального введения |
| CA2669938C (en) * | 2006-11-15 | 2016-01-05 | Abbott Laboratories | Solid pharmaceutical dosage formulations |
| DE102007011485A1 (de) | 2007-03-07 | 2008-09-11 | Grünenthal GmbH | Darreichungsform mit erschwertem Missbrauch |
| EP2219624A2 (en) | 2007-11-08 | 2010-08-25 | Glaxo Group Limited | Pharmaceutical formulations |
| EP2249808A2 (en) * | 2008-01-11 | 2010-11-17 | Cipla Limited | Solid pharmaceutical dosage form |
| US8383152B2 (en) | 2008-01-25 | 2013-02-26 | Gruenenthal Gmbh | Pharmaceutical dosage form |
| SI2273983T1 (sl) | 2008-05-09 | 2016-11-30 | Gruenenthal Gmbh | Postopek za pripravo intermediatne praškaste formulacije in končne trdne odmerne oblike z uporabo stopnje strjevanja z razprševanjem |
| CA2727630A1 (en) * | 2008-06-13 | 2009-12-17 | Glaxo Group Limited | Pharmaceutical formulations |
| US8041893B1 (en) | 2008-09-09 | 2011-10-18 | Vignette Software Llc | System and method for managing large filesystem-based caches |
| EP2373346B1 (en) | 2008-09-10 | 2019-06-12 | BioChemics, Inc. | Ibuprofen for topical administration |
| EP2207536A1 (en) | 2008-09-22 | 2010-07-21 | BioChemics, Inc. | Transdermal drug delivery using an osmolyte and vasoactive agent |
| TW201105316A (en) | 2009-07-22 | 2011-02-16 | Gruenenthal Gmbh | Hot-melt extruded pharmaceutical dosage form |
| AU2010275755B2 (en) * | 2009-07-22 | 2014-04-24 | Grünenthal GmbH | Oxidation-stabilized tamper-resistant dosage form |
| CN102821757B (zh) * | 2010-02-03 | 2016-01-20 | 格吕伦塔尔有限公司 | 通过挤出机制备粉末状药物组合物 |
| CN103179954A (zh) | 2010-09-02 | 2013-06-26 | 格吕伦塔尔有限公司 | 包含阴离子聚合物的抗破碎剂型 |
| MX2013002377A (es) | 2010-09-02 | 2013-04-29 | Gruenenthal Gmbh | Forma de dosificacion resistente a manipulacion que comprende una sal inorganica. |
| US9308213B2 (en) | 2010-10-29 | 2016-04-12 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
| US11224659B2 (en) | 2010-10-29 | 2022-01-18 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
| US11202831B2 (en) | 2010-10-29 | 2021-12-21 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
| US11730709B2 (en) | 2010-10-29 | 2023-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
| US9744132B2 (en) | 2010-10-29 | 2017-08-29 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
| EP2675434A1 (en) | 2011-02-17 | 2013-12-25 | F.Hoffmann-La Roche Ag | A process for controlled crystallization of an active pharmaceutical ingredient from supercooled liquid state by hot melt extrusion |
| RS56527B1 (sr) | 2011-07-29 | 2018-02-28 | Gruenenthal Gmbh | Tableta za trenutno oslobađanje leka rezistentna na zloupotrebu |
| US10201502B2 (en) | 2011-07-29 | 2019-02-12 | Gruenenthal Gmbh | Tamper-resistant tablet providing immediate drug release |
| MX356421B (es) | 2012-02-28 | 2018-05-29 | Gruenenthal Gmbh | Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico. |
| EA201401139A1 (ru) | 2012-04-18 | 2015-03-31 | Грюненталь Гмбх | Устойчивая к разрушению и к сбросу дозы фармацевтическая лекарственная форма |
| US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
| BR112015026549A2 (pt) | 2013-05-29 | 2017-07-25 | Gruenenthal Gmbh | forma de dosagem à prova de violação contendo uma ou mais partículas |
| CA2913209A1 (en) | 2013-05-29 | 2014-12-04 | Grunenthal Gmbh | Tamper resistant dosage form with bimodal release profile |
| CA2917136C (en) | 2013-07-12 | 2022-05-31 | Grunenthal Gmbh | Tamper-resistant dosage form containing ethylene-vinyl acetate polymer |
| WO2015078891A1 (en) | 2013-11-26 | 2015-06-04 | Farmaceutici Formenti S.P.A. | Preparation of a powdery pharmaceutical composition by means of cryo-milling |
| UY36046A (es) * | 2014-03-26 | 2015-10-30 | Millennium Pharm Inc | Formulaciones farmacéuticas, procesos para la preparación y métodos de uso |
| WO2015173195A1 (en) | 2014-05-12 | 2015-11-19 | Grünenthal GmbH | Tamper resistant immediate release capsule formulation comprising tapentadol |
| MX2016015417A (es) | 2014-05-26 | 2017-02-22 | Gruenenthal Gmbh | Multiparticulas protegidas contra vertido de dosis etanolico. |
| GB201502077D0 (en) * | 2015-02-09 | 2015-03-25 | Cubic Pharmaceuticals Ltd And Delta Pharmaceuticals Ltd | Improved hme technology |
| WO2016128235A1 (en) | 2015-02-11 | 2016-08-18 | Nestec S.A. | Vitamin a composition |
| EP3285745A1 (en) | 2015-04-24 | 2018-02-28 | Grünenthal GmbH | Tamper-resistant dosage form with immediate release and resistance against solvent extraction |
| JP2018526414A (ja) | 2015-09-10 | 2018-09-13 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1766546C3 (de) * | 1968-06-11 | 1974-11-28 | Karl Gunnar Lidingoe Eriksson | Verfahren zum Herstellen von festen dragee- oder tablettenförmigen Arzneimittelzubereitungen |
| DE3612211A1 (de) * | 1986-04-11 | 1987-10-15 | Basf Ag | Kontinuierliches verfahren zum tablettieren |
| DE3830353A1 (de) * | 1988-09-07 | 1990-03-15 | Basf Ag | Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen |
| ATE159426T1 (de) * | 1991-04-16 | 1997-11-15 | Nippon Shinyaku Co Ltd | Verfahren zur herstellung einer festen dispersion |
| SK281042B6 (sk) * | 1992-09-18 | 2000-11-07 | Yamanouchi Pharmaceutical Co., Ltd | Prípravok hydrogélového typu s ustáleným uvoľňovaním |
-
1995
- 1995-03-21 DE DE19509807A patent/DE19509807A1/de not_active Withdrawn
-
1996
- 1996-03-12 MX MX9605678A patent/MX9605678A/es not_active IP Right Cessation
- 1996-03-12 EP EP96907439A patent/EP0760654B1/de not_active Expired - Lifetime
- 1996-03-12 HU HU9603530A patent/HUP9603530A3/hu unknown
- 1996-03-12 CZ CZ963405A patent/CZ340596A3/cs unknown
- 1996-03-12 AT AT96907439T patent/ATE204162T1/de not_active IP Right Cessation
- 1996-03-12 ES ES96907439T patent/ES2163008T3/es not_active Expired - Lifetime
- 1996-03-12 US US08/737,745 patent/US5741519A/en not_active Expired - Lifetime
- 1996-03-12 CN CN96190364A patent/CN1081458C/zh not_active Expired - Lifetime
- 1996-03-12 JP JP52804396A patent/JP4017661B2/ja not_active Expired - Lifetime
- 1996-03-12 DE DE59607490T patent/DE59607490D1/de not_active Expired - Lifetime
- 1996-03-12 BR BR9605886A patent/BR9605886A/pt not_active Application Discontinuation
- 1996-03-12 CA CA002190882A patent/CA2190882C/en not_active Expired - Lifetime
- 1996-03-12 AU AU51069/96A patent/AU5106996A/en not_active Abandoned
- 1996-03-12 KR KR1019960706601A patent/KR970703133A/ko not_active Application Discontinuation
- 1996-03-12 WO PCT/EP1996/001047 patent/WO1996029061A1/de active IP Right Grant
- 1996-03-18 IL IL11753296A patent/IL117532A0/xx unknown
- 1996-03-20 ZA ZA9602243A patent/ZA962243B/xx unknown
- 1996-11-20 NO NO19964939A patent/NO313485B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA962243B (en) | 1997-09-22 |
| JP4017661B2 (ja) | 2007-12-05 |
| CN1150757A (zh) | 1997-05-28 |
| CA2190882A1 (en) | 1996-09-26 |
| ATE204162T1 (de) | 2001-09-15 |
| NO313485B1 (no) | 2002-10-14 |
| DE59607490D1 (de) | 2001-09-20 |
| NO964939L (no) | 1997-01-17 |
| NO964939D0 (no) | 1996-11-20 |
| US5741519A (en) | 1998-04-21 |
| MX9605678A (es) | 1998-04-30 |
| IL117532A0 (en) | 1996-07-23 |
| JPH10501000A (ja) | 1998-01-27 |
| HU9603530D0 (en) | 1997-02-28 |
| ES2163008T3 (es) | 2002-01-16 |
| CA2190882C (en) | 2007-01-16 |
| HUP9603530A3 (en) | 2001-12-28 |
| EP0760654B1 (de) | 2001-08-16 |
| AU5106996A (en) | 1996-10-08 |
| WO1996029061A1 (de) | 1996-09-26 |
| CN1081458C (zh) | 2002-03-27 |
| KR970703133A (ko) | 1997-07-03 |
| CZ340596A3 (en) | 1997-06-11 |
| DE19509807A1 (de) | 1996-09-26 |
| HU76547A2 (en) | 1997-09-29 |
| EP0760654A1 (de) | 1997-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9605886A (pt) | Processo para produção de composições de substância ativa na forma de uma solução sólida da substância atina em uma matriz de polímero e composição de substância ativa | |
| ATE204466T1 (de) | Zusammensetzung, die ein in einem glasbildenden träger gelösten wirkstoff enthalt und ein verfahren zu deren herstellung | |
| DK0797609T3 (da) | Polyestere | |
| FI103091B1 (fi) | Menetelmä viivästyneesti vapauttavan koostumuksen valmistamiseksi | |
| ATE171613T1 (de) | Verfahren zur herstellung von teilbaren tabletten | |
| BR9607867A (pt) | Composição transparente de um analgésico não-asteróide de liberação rapida e processo para produção da mesma | |
| ES2111504T1 (es) | Fibras vitreas artificiales. | |
| ATE214595T1 (de) | Verfahren zur herstellung von lösungsmittelfreien nicht-kristallinen biologisch aktiven substanzen | |
| BR9907895A (pt) | Processo para preparar uma composição denanocompósito polimérica | |
| PL314188A1 (en) | Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions | |
| DE69932620D1 (de) | Hydratformen des natriumsalzes von alendronat, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die diese enthalten | |
| AR021777A1 (es) | UNA COMPOSICIoN PARA ACONDICIONAR, ACLARAR E ILUMINAR EL CABELLO Y UN MÉTODO PARA ACONDICIONAR, ACLARAR E ILUMINAR EL CABELLO. | |
| ES2117804T3 (es) | Empleo de mezclas detergentes para la fabricacion de pastillas para inodoro. | |
| DK0868437T3 (da) | Fremgangsmåde til fremstilling af hyaluronsyrefraktion med et lavt polydispersionsindeks | |
| DE59706324D1 (de) | Schmelzbare stabilisatorkombination | |
| ES2188011T3 (es) | Agente de contraste para la reproduccion en imagenes de infartos y necrosis. | |
| ATE264332T1 (de) | Galanthamin-derivate, verfahren zu ihrer herstellung, ihre verwendung als arzmittel und diese enthaltende pharmazeutische zusammensetzung | |
| ATE186711T1 (de) | Zeolithe und verfahren zu ihrer herstellung | |
| BR9805600A (pt) | Pó de agente de sopro e processo para a produção do mesmo. | |
| ES2136401T3 (es) | Procedimiento para la fabricacion de cuerpos moldeados. | |
| BR9507310A (pt) | Processo para a fabricação de uma célula eletroquimica | |
| FI970330A (fi) | Imidatsopyridiini-atsolidinonit | |
| ATE135703T1 (de) | Substituierte 2-imidazoline und verfahren zur herstellung sowie deren verwendung | |
| DE59607683D1 (de) | Neue borneolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung | |
| ES2098969T3 (es) | Metodo para la eliminacion de impurezas que contienen grupos nitrilo a partir de polimeros. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Application withdrawn |